PT  - JOURNAL ARTICLE
ED  - Bhatt, Deepak
TI  - CHARISMA
DP  - 2006 May 01
TA  - MD Conference Express
PG  - 12--12
VI  - 6
IP  - 1
4099  - http://mdc.sagepub.com/content/6/1/12.short
4100  - http://mdc.sagepub.com/content/6/1/12.full
AB  - CHARISMA (Clopidogrel for High Atherothrombotic Risk, Ischemic Stabilization, Management, and Avoidance) is the first clinical trial to evaluate long-term effectiveness of clopidogrel plus aspirin in a population of high-risk patients, including symptomatic individuals with documented disease. Principal investigator Deepak Bhatt, MD, of the Cleveland Clinic Cardiovascular Coordinating Center, presented results from more than 15,000 study participants followed for a median of 2.3 years.